Ventas (VTR) Raised to Buy at ValuEngine

Ventas (NYSE:VTR) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a note issued to investors on Friday.

A number of other research analysts have also issued reports on the stock. KeyCorp reiterated a “sell” rating and set a $55.00 price target on shares of Ventas in a research note on Sunday, September 17th. Capital One Financial upgraded shares of Ventas from an “equal weight” rating to an “overweight” rating in a research note on Monday, October 30th. Zacks Investment Research lowered shares of Ventas from a “hold” rating to a “sell” rating in a research note on Wednesday, November 15th. UBS Group lowered shares of Ventas from a “market perform” rating to an “underperform” rating in a research note on Monday, December 4th. Finally, BMO Capital Markets set a $62.00 price target on shares of Ventas and gave the stock a “sell” rating in a research note on Friday, October 27th. Eight equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $64.44.

Shares of Ventas (VTR) traded down $0.30 during trading hours on Friday, hitting $58.35. 2,449,700 shares of the stock were exchanged, compared to its average volume of 2,204,275. Ventas has a 1-year low of $57.90 and a 1-year high of $72.36. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 1.06. The stock has a market capitalization of $20,770.00, a PE ratio of 34.73, a price-to-earnings-growth ratio of 3.81 and a beta of 0.09.

Ventas (NYSE:VTR) last announced its earnings results on Friday, October 27th. The real estate investment trust reported $0.44 EPS for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.60). Ventas had a net margin of 32.96% and a return on equity of 6.34%. The business had revenue of $899.90 million during the quarter, compared to analysts’ expectations of $893.18 million. During the same period in the previous year, the company posted $1.03 earnings per share. Ventas’s quarterly revenue was up 3.8% on a year-over-year basis. equities research analysts forecast that Ventas will post 4.16 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently modified their holdings of the business. Bronfman E.L. Rothschild L.P. grew its position in Ventas by 48.0% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 2,003 shares of the real estate investment trust’s stock worth $139,000 after buying an additional 650 shares during the period. Amica Retiree Medical Trust acquired a new position in Ventas during the third quarter worth about $131,000. Cable Hill Partners LLC acquired a new position in Ventas during the third quarter worth about $174,000. Carnick & Kubik Group LLC acquired a new position in Ventas during the third quarter worth about $204,000. Finally, Vident Investment Advisory LLC acquired a new position in Ventas during the third quarter worth about $206,000. Institutional investors own 90.01% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2018/01/05/ventas-vtr-raised-to-buy-at-valuengine.html.

About Ventas

Ventas, Inc is a real estate investment trust (REIT) with its properties located throughout the United States, Canada and the United Kingdom. The Company operates through three segments: triple-net leased properties, senior living operations and office operations. Under its triple-net leased properties segment, the Company invests in and owns seniors housing and healthcare properties throughout the United States and the United Kingdom and leases those properties to healthcare operating companies under triple-net or absolute-net leases that obligate the tenants to pay all property-related expenses.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply